��������

Professor Sir Peter Ratcliffe has over 30 years’ of experience as a clinically active physician-scientist. He currently serves as Director of Clinical Research at The Francis Crick Institute in London Director of the Target Discovery Institute and Distinguished Scholar of the Ludwig Institute for Cancer Research within the Nuffield Department of Medicine at the University of Oxford. Sir Peter was elected to the Fellowship of the Royal Society and to the Academy of Medical Sciences in 2002. He is a member of the European Molecular Biology Organization (EMBO), a foreign honorary member of the American Academy of Arts and Sciences, and a Fellow of the American Association for Cancer Research (AACR) Academy. His work has been recognized through a number of awards, including the Louis‐Jeantet Prize in Medicine, the Canada Gairdner International Award, and the Lasker Award for Basic Biomedical Research. In 2019, he shared the Nobel Prize for Physiology or Medicine for the discovery of the key mechanisms that cells use to detect and respond to hypoxia (low oxygen levels), opening up promising new ways to tackle cancer, anaemia, and many other diseases. He was knighted for services to medicine in 2014.